
Susan Nmn Ungar
Examiner (ID: 13594)
| Most Active Art Unit | 1642 |
| Art Unit(s) | 2899, 1642, 1806 |
| Total Applications | 662 |
| Issued Applications | 234 |
| Pending Applications | 203 |
| Abandoned Applications | 225 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6755326
[patent_doc_number] => 20030003103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-02
[patent_title] => 'Sequences for targeting metastatic cells'
[patent_app_type] => new
[patent_app_number] => 10/151055
[patent_app_country] => US
[patent_app_date] => 2002-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14456
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20030003103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10151055
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/151055 | Sequences for targeting metastatic cells | May 20, 2002 | Abandoned |
| 09/958398 | Telomerase-specific cancer vaccine | May 16, 2002 | Abandoned |
Array
(
[id] => 6668913
[patent_doc_number] => 20030113897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Mutant p21Cip1/WAF1 and cell growth control and cell growth control'
[patent_app_type] => new
[patent_app_number] => 10/142174
[patent_app_country] => US
[patent_app_date] => 2002-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 48759
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113897.pdf
[firstpage_image] =>[orig_patent_app_number] => 10142174
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/142174 | Mutant p21Cip1/WAF1 and cell growth control and cell growth control | May 8, 2002 | Abandoned |
Array
(
[id] => 6653112
[patent_doc_number] => 20030008840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Methods for treating cancer'
[patent_app_type] => new
[patent_app_number] => 10/140802
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11293
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10140802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/140802 | Methods for treating cancer | May 6, 2002 | Abandoned |
Array
(
[id] => 6766125
[patent_doc_number] => 20030100525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Survivin, a protein that inhibits cellular apoptosis, and its modulation'
[patent_app_type] => new
[patent_app_number] => 10/138618
[patent_app_country] => US
[patent_app_date] => 2002-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 25449
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138618 | Survivin, a protein that inhibits cellular apoptosis, and its modulation | May 5, 2002 | Issued |
Array
(
[id] => 6660146
[patent_doc_number] => 20030134790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer'
[patent_app_type] => new
[patent_app_number] => 10/139814
[patent_app_country] => US
[patent_app_date] => 2002-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15064
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134790.pdf
[firstpage_image] =>[orig_patent_app_number] => 10139814
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/139814 | Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer | May 1, 2002 | Abandoned |
Array
(
[id] => 6725028
[patent_doc_number] => 20030207340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Sequences encoding human neoplastic marker'
[patent_app_type] => new
[patent_app_number] => 10/138195
[patent_app_country] => US
[patent_app_date] => 2002-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15265
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10138195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/138195 | Sequences encoding human neoplastic marker | Apr 30, 2002 | Abandoned |
Array
(
[id] => 6796927
[patent_doc_number] => 20030175801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals'
[patent_app_type] => new
[patent_app_number] => 10/124862
[patent_app_country] => US
[patent_app_date] => 2002-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29411
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124862 | Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals | Apr 17, 2002 | Abandoned |
Array
(
[id] => 6782938
[patent_doc_number] => 20030064385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Genes expressed in breast cancer as prognostic and therapeutic targets'
[patent_app_type] => new
[patent_app_number] => 10/120583
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29150
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064385.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120583
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120583 | Genes expressed in breast cancer as prognostic and therapeutic targets | Apr 10, 2002 | Abandoned |
Array
(
[id] => 6473650
[patent_doc_number] => 20020151517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Nucleosome-based anti-tumor compositions'
[patent_app_type] => new
[patent_app_number] => 10/118802
[patent_app_country] => US
[patent_app_date] => 2002-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6303
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151517.pdf
[firstpage_image] =>[orig_patent_app_number] => 10118802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/118802 | Nucleosome-based anti-tumor compositions | Apr 8, 2002 | Abandoned |
Array
(
[id] => 6679763
[patent_doc_number] => 20030229904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 10/120885
[patent_app_country] => US
[patent_app_date] => 2002-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 94773
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120885 | Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer | Apr 8, 2002 | Abandoned |
Array
(
[id] => 6787199
[patent_doc_number] => 20030138438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Compositions and methods for the therapy and diagnosis of lung cancer'
[patent_app_type] => new
[patent_app_number] => 10/117982
[patent_app_country] => US
[patent_app_date] => 2002-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70965
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10117982
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/117982 | Compositions and methods for the therapy and diagnosis of lung cancer | Apr 4, 2002 | Abandoned |
Array
(
[id] => 7447669
[patent_doc_number] => 20040003418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 10/107532
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 120650
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20040003418.pdf
[firstpage_image] =>[orig_patent_app_number] => 10107532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/107532 | Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer | Mar 24, 2002 | Abandoned |
Array
(
[id] => 7126907
[patent_doc_number] => 20050058651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Compositions and methods to prevent metastasis from primary malignancies'
[patent_app_type] => utility
[patent_app_number] => 10/468388
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13711
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468388 | Compositions and methods to prevent metastasis from primary malignancies | Mar 20, 2002 | Abandoned |
| 10/018396 | Extracellular camp-dependent protein kinase in diagnosis, prognosis and treatment of cancer | Mar 19, 2002 | Abandoned |
Array
(
[id] => 6730051
[patent_doc_number] => 20030186241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Human choline/ethanolamine kinase (HCEK)-related gene variant associated with lung cancers'
[patent_app_type] => new
[patent_app_number] => 10/102556
[patent_app_country] => US
[patent_app_date] => 2002-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 5609
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186241.pdf
[firstpage_image] =>[orig_patent_app_number] => 10102556
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/102556 | Human choline/ethanolamine kinase (HCEK)-related gene variant associated with lung cancers | Mar 19, 2002 | Abandoned |
Array
(
[id] => 6710496
[patent_doc_number] => 20030170245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Activation of matriptase and diagnostic and therapeutic methods based thereon'
[patent_app_type] => new
[patent_app_number] => 10/087987
[patent_app_country] => US
[patent_app_date] => 2002-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 15632
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170245.pdf
[firstpage_image] =>[orig_patent_app_number] => 10087987
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/087987 | Activation of matriptase and diagnostic and therapeutic methods based thereon | Mar 4, 2002 | Abandoned |
Array
(
[id] => 6047650
[patent_doc_number] => 20020168662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'Sperm protein 17 for the diagnosis and treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/082959
[patent_app_country] => US
[patent_app_date] => 2002-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6913
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168662.pdf
[firstpage_image] =>[orig_patent_app_number] => 10082959
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/082959 | Sperm protein 17 for the diagnosis and treatment of cancer | Feb 25, 2002 | Issued |
Array
(
[id] => 6375152
[patent_doc_number] => 20020119189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Nucleosome-based anti-tumor compositions'
[patent_app_type] => new
[patent_app_number] => 10/081223
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6351
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119189.pdf
[firstpage_image] =>[orig_patent_app_number] => 10081223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/081223 | Nucleosome-based anti-tumor compositions | Feb 21, 2002 | Abandoned |
Array
(
[id] => 6655553
[patent_doc_number] => 20030077603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Methods and compositions for diagnosis of hepatoma'
[patent_app_type] => new
[patent_app_number] => 10/079596
[patent_app_country] => US
[patent_app_date] => 2002-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 35178
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077603.pdf
[firstpage_image] =>[orig_patent_app_number] => 10079596
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/079596 | Methods and compositions for diagnosis of hepatoma | Feb 18, 2002 | Abandoned |